Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials (Q37539431)

20 August 2017

1 reference

title

Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials (English)

1 reference

adaptive radiation therapy

20 August 2017

main subject

0 references

1 reference

Víctor Macías

1

0 references

author name string

Albert Biete

series ordinal

2

1 reference

20 August 2017

publication date

1 July 2009

1 reference

Clinical and Translational Oncology

20 August 2017

published in

1 reference

20 August 2017

volume

11

1 reference

20 August 2017

issue

7

1 reference

20 August 2017

page(s)

437-445

1 reference

Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

Combined hypofractionated radiation and hormone therapy for the treatment of intermediate-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

Evaluation of image-guided radiation therapy (IGRT) technologies and their impact on the outcomes of hypofractionated prostate cancer treatments: a radiobiologic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

Evidence of limited motion of the prostate by carefully emptying the rectum as assessed by daily MVCT image guidance with helical tomotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

The impact of geometric uncertainty on hypofractionated external beam radiation therapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

Phase II Trial of Hypofractionated Image-Guided Intensity-Modulated Radiotherapy for Localized Prostate Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-009-0382-2

Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: impact of rectal dose in high-dose-rate brachytherapy on occurrence of grade 2 or worse rectal bleeding

21 January 2018

1 reference

12 December 2020

Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose.

1 reference

12 December 2020

The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE)

1 reference

12 December 2020

Comparison of alpha/beta estimates from homogeneous (individual) and heterogeneous (population) tumor control models for early stage prostate cancer

1 reference

12 December 2020

Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience

1 reference

12 December 2020

Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute

1 reference

12 December 2020

In regard to Brenner et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio) similar to late-responding normal tissue.

1 reference

12 December 2020

Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer

1 reference

12 December 2020

[Robotic radiotherapy for prostate cancer with CyberKnife]

1 reference

12 December 2020

Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy

1 reference

12 December 2020

Fractionation and protraction for radiotherapy of prostate carcinoma

1 reference

12 December 2020

What hypofractionated protocols should be tested for prostate cancer?

1 reference

12 December 2020

[A preliminary safety study of hypofractionated radiotherapy for local prostate cancer]

1 reference

12 December 2020

1 reference

12 December 2020

Target motion variability and on-line positioning accuracy during external-beam radiation therapy of prostate cancer with an endorectal balloon device.

1 reference

12 December 2020

Effect of heterogeneity in radiosensitivity on LQ based isoeffect formalism for low α/β cancers

1 reference

12 December 2020

Reduction in acute morbidity using hypofractionated intensity-modulated radiation therapy assisted with a fluoroscopic real-time tumor-tracking system for prostate cancer: preliminary results of a phase I/II study.

1 reference

12 December 2020

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

12 December 2020

Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate cancer

1 reference

12 December 2020

Is the prostrate alpha/beta ratio of 1.5 from Brenner & Hall a modeling artifact

1 reference

12 December 2020

Outcome analysis of 300 prostate cancer patients treated with neoadjuvant androgen deprivation and hypofractionated radiotherapy

1 reference

12 December 2020

Early and late injuries in mouse rectum after fractionated X-ray and neutron irradiation

1 reference

12 December 2020

Alpha/beta value and importance of dose per fraction for the late rectal and recto-sigmoid complications

1 reference

12 December 2020

Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio.

1 reference

12 December 2020

Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique

1 reference

12 December 2020

Halftime for repair of sublethal damage in normal bladder and rectum: an analysis of clinical data from cervix brachytherapy

1 reference

12 December 2020

Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity.

1 reference

12 December 2020

Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results

1 reference

12 December 2020

Transabdominal ultrasonography, computed tomography and electronic portal imaging for 3-dimensional conformal radiotherapy for prostate cancer

1 reference

12 December 2020

Is There a Detrimental Effect of Waiting for Radiotherapy for Patients With Localized Prostate Cancer?

1 reference

12 December 2020

Acute toxicity after hypofractionated conformal radiotherapy for localized prostate cancer: nonrandomized contemporary comparison with standard fractionation

1 reference

12 December 2020

TCP isoeffect analysis using a heterogeneous distribution of radiosensitivity

1 reference

12 December 2020

Hypofractionated conformal HDR brachytherapy in hormone naïve men with localized prostate cancer. Is escalation to very high biologically equivalent dose beneficial in all prognostic risk groups?

1 reference

12 December 2020

Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate

1 reference

12 December 2020

Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: rationale, technique and early experience.

1 reference

12 December 2020

High-dose-rate brachytherapy as monotherapy for localized prostate cancer: A retrospective analysis with special focus on tolerance and chronic toxicity

1 reference

12 December 2020

Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives.

1 reference

12 December 2020

Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study

1 reference

12 December 2020

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue

1 reference

12 December 2020

Clinical and Dosimetric Predictors of Acute Toxicity After a 4-Week Hypofractionated External Beam Radiotherapy Regimen for Prostate Cancer: Results From a Multicentric Prospective Trial

1 reference

12 December 2020

Prostate intrafraction motion evaluation using kV fluoroscopy during treatment delivery: a feasibility and accuracy study.

1 reference

12 December 2020

The α/β ratio for prostate cancer: What is it, really?

1 reference

12 December 2020

Radiation tolerance of the rat rectum to fractionated X-rays and pi-mesons

1 reference

12 December 2020

Consequential late effects in normal tissues

1 reference

12 December 2020

Fractionation and late rectal toxicity

1 reference

12 December 2020

Hypofractionation for prostate cancer: a critical review

1 reference

12 December 2020

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

12 December 2020

Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume.

1 reference

12 December 2020

High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer

1 reference

12 December 2020

Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study.

1 reference

12 December 2020

Investigation of linac-based image-guided hypofractionated prostate radiotherapy.

1 reference

12 December 2020

Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials?

1 reference

12 December 2020

How low is the alpha/beta ratio for prostate cancer?

1 reference

12 December 2020

Is alpha/beta for prostate tumors really low?

1 reference

12 December 2020

Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique: analysis of 542 consecutive patients

1 reference

12 December 2020

The effects of delays in radiotherapy treatment on tumour control

1 reference

12 December 2020

Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate Cancer

1 reference

12 December 2020

10.1007/S12094-009-0382-2

Identifiers

DOI

1 reference

20 August 2017

1 reference